PUNE, India, April 28, 2016 /PRNewswire/ --

New market research titled "Osteoarthritis - Pipeline Review, H1 2016" is a report that provides an overview of the Osteoarthritis's therapeutic pipeline and helps strengthen R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Company Profiles discussed in this H1 2016 Osteoarthritis Pipeline report include A. Menarini Industrie Farmaceutiche Riunite Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, Inc., Addex Therapeutics Ltd, Akari Therapeutics, Plc, Amura Holdings Limited, Arcarios BV, Asahi Kasei Pharma Corp., Asklepios BioPharmaceutical, Inc., Astellas Pharma Inc., Asterias Biotherapeutics, Inc., Axsome Therapeutics, Inc., Biopharm GmbH, Can-Fite BioPharma Ltd., Cara Therapeutics, Inc., Cardax Pharmaceuticals, Inc., Cellceutix Corporation, Cellular Biomedicine Group, Inc., Chong Kun Dang Pharmaceutical Corp., Dong-A ST Co., Ltd., Eli Lilly and Company, Evgen Pharma PLC, Galapagos NV, Genequine Biotherapeutics GmbH, GlaxoSmithKline Plc, IntelliCell BioSciences Inc., Jeil Pharmaceutical Co., Ltd., Jenrin Discovery, Inc., K-Stemcell Co., Ltd., Levolta Pharmaceuticals, Inc., Medivir AB, Merck KGaA, Mesoblast Limited, Mor Research Application Ltd, NicOx S.A., Nordic Bioscience A/S, Novartis AG, Ocata Therapeutics, Inc., Omeros Corporation, Ono Pharmaceutical Co., Ltd., OrthoCyte Corporation, Osteologix Holdings Plc, Pfizer Inc., Pharmalink AB, PLx Pharma Inc., ProteoThera, Inc., Regeneus Ltd, ReqMed Company, Ltd., Sanofi, Seikagaku Corporation, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., STELIS Biopharma Pvt. Ltd., Stempeutics Research Private Limited, Symic Biomedical, Inc., Takeda Pharmaceutical Company Limited, TissueGene, Inc., Upsher-Smith Laboratories, Inc., Yooyoung Pharmaceutical Co., Ltd., Yuhan Corporation, Yungjin Pharm. Co., Ltd., Zimmer Biomet Holdings, Inc. and Zynerba Pharmaceuticals, Inc.

Complete report on H1 2016 pipeline review of Osteoarthritis with 102 market data tables and 17 figures, spread across 108 pages is available at http://www.reportsnreports.com/reports/531489-osteoarthritis-pipeline-review-h1-2016.html .

Drugs Profiles discussed in this report include (apocynin + paeonol), (clodronate disodium + hyaluronic acid), ABT-981, AlloJoin, AM-3701, AM-3876, Anatabine, Antibody for Osteoarthritis, Antibody to Inhibit TGF-Beta 1 for Osteoarthritis, ARC, AS-001, ASP-7962, BNP-OA, BRM-421, CDX-085, celecoxib, CHND-1, CKD-941, clodronate disodium, CR-8357, CR-845, CRB-0017, CS-30MS02, DA-5202, DIS-BIO-EPS, DNX-314, Drug for Bone Diseases and Osteoarthritis, Drug for Osteoarthritis, Drugs to Inhibit Renin Angiotensin for Osteoarthritis, Drugs to Modulate Bone Morphogenetic Protein for Osteoarthritis and Fracture, Drugs to Modulate PPAR-Delta for Immunology, Metabolic and Musculoskeletal Disorders, duloxetine hydrochloride DR, fasitibant chloride, GLPG-1972, GQ-203, GQ-303, GSK-2394002, GZ-389988, JD-4000 Series, Kartogenin, KBP-056, ketoprofen, KM-278, LEVI-04, LH-023, LNA-043, MIV-711, Monoclonal Antibodies for Inflammation and Osteoarthritis, Monoclonal Antibody for Osteoarthritis, MOR-106, MSBCAR-001, naproxcinod, NBS-101, NStride APS, OAX-1, ONO-4474, OTXCP-03, OTXCP-07, pentosan polysulfate sodium, Peptide for Osteoarthritis, piclidenoson, PL-1100, PRO-1, Progenza, Protein for Osteoarthritis, Protein for Osteoarthritis and Asthma, Protein for Rheumatoid Arthritis and Osteoarthritis, Protein to Activate BMP-7 for Obesity, Osteoarthritis, Kidney Fibrosis and Alport Syndrome, PRX-167700, Recombinant Peptides for Osteoarthritis, Recombinant Protein to Activate IL-4 and IL-10 Receptors for Osteoarthritis and CNS, Recombinant Protein to Agonize IGF-1 Receptor for Osteoarthritis, Recombinant Protein to Agonize PTH Receptor for Osteoporosis and Osteoarthritis, ReJoin, Salmon Calcitonin, SAR-396049, SB-061, SBL-005, SI-613, SM-04690, Small Molecule for Degenerative Arthritis, Small Molecule for Osteoarthritis, Small Molecule to Agonize A2A for Immunology, Hematological and Neurological Disorders, Small Molecule to Inhibit MMP13 for Osteoarthritis, Small Molecule to Target GPR22 for Anxiety, Cardiovascular Diseases and Osteoarthritis, Small Molecules for Immunology, Metabolic and Musculoskeletal Disorders, Small Molecules for Immunology, Musculoskeletal and Metabolic Disorders, Small Molecules for Osteoarthritis, Small Molecules to Antagonize TNFR1 for Immunology, Gastrointestinal, Neurology and Hematological Disorders, Small Molecules to Inhibit ADAMTS-5 for Osteoarthritis, Small Molecules to Inhibit Complement System Protein for Osteoarthritis, Small Molecules to Inhibit Kinase for Osteoarthritis and Osteoporosis, Small Molecules to Inhibit MMP-13 for Osteoarthritis, sprifermin, Stem Cell Therapy for Autoimmune Diseases, Stem Cell therapy for CNS, CVS, Dermatological, Immnuological and Metabolic Disorders, Stem Cell Therapy for Degenerative Arthritis, Stem Cell Therapy for Knee Osteoarthritis, Stem Cell Therapy for Multiple Sclerosis, Rheumatoid Arthritis, Osteoarthritis, Autism, Bronchopulmonary Dysplasia, Heart Failure and Cerebral Palsy, Stem Cell Therapy for Osteoarthritis, Stem Cell Therapy for Osteoarthritis, Diabetes Mellitus, Acute Liver Failure, Post Cardiopulmonary Resuscitation and Neurodegenerative Diseases, Stempeucel, Stromal Cell Therapy for Arthritis, Sulforadex, tonogenchoncel-L, TPX-100, TRBN-0224, UGP-302, VOLT-01, X-0002, XT-101, XT-150, YH-14619, YRA-1909, YY-1201, zoledronic acid and ZYN-002.

Order a copy of H1 2016 Osteoarthritis pipeline market research report @ http://www.reportsnreports.com/Purchase.aspx?name=531489 .

This report provides comprehensive information on the therapeutic development for Osteoarthritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

Explore more reports on Pharmaceuticals.

About Us:   

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Connect With Us on:
Facebook: https://www.facebook.com/ReportsnReports/
LinkedIn: https://www.linkedin.com/company/reportsnreports
Twitter: https: //twitter.com/marketsreports
G+ / Google Plus: https://plus.google.com/111656568937629536321/posts
RSS/Feeds: http://www.reportsnreports.com/feed/l-latestreports.xml

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
+ 1 888 391 5441
sales@reportsandreports.com

SOURCE ReportsnReports